Particles Filtration Not Acceptable
Recommendation
17-19 September 2024
GMP Compliance and Technology for the Manufacture of Oral Solid Dosage Forms
Register now for ECA's GMP Newsletter
The European Medicines Agency (EMA) has recently added an interesting question to its Questions & Answers section. How acceptable is filtration of particles prior to the administration of a medicinal product for parenteral use? This question addresses the problem of particles for example due to delamination of glass or rubber particles following puncture of the rubber stopper. The question is asked whether this might be compensated by a user instruction to apply a specific filter before use.
As might be expected, the answer of the EMA is an unequivocal "no". The responsibility for high-quality products can't be transferred to the patient. In certain cases, one would rather speak of a modification of the original formulation to avoid - for example - delamination of glass.
More detailed information is available in the original text of the Q&A section on the EMA website.
Related GMP News
03/04/2024
06/03/2024
GMP Conferences by Topics
- General Quality Assurance and GMP Compliance Topics
- Hygiene
- General Microbiology Topics
- Regulatory Affairs
- Development
- General Analytics Topics
- Good Distribution Practice
- Sterile Manufacturing
- Computer Validation
- General Qualification/Validation Topics
- General Engineering Topics
- APIs/Excipients
- GMP Basic Training Courses
- Medical Devices and Combination Products
- Packaging and Packaging Material
- Data Integrity
- Qualified Person (QP)
- GMP Auditing
- Documentation
- Cleaning Validation
- General IT Compliance Topics
- Impurities
- OOS / OOE / OOT
- Material Testing
- Validation of Analytical Methods
- Analytical Instrument Qualification
- Stability Testing
- Microbiological Testing
- Technology
- General Manufacturing Topics
- Solid Dosage Forms/Semi-Solid Dosage Forms
- Biotechnology/Blood/ATMP
- Herbal Drug Products/Cannabis/Radiopharmaceuticals
- Others